ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,015Medicare Part D Prescriptions Filled, Including Refills

Rank: 350 out of 955

$370K Total Retail Price of All Prescriptions

Rank: 417 out of 955

357 Patients Receiving at Least One Drug in Part D
81% Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Arkansas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 357 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $47 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 488 387 99 1 4
AMLODIPINE BESYLATE 360 291 61 2 6
LEVOTHYROXINE SODIUM 349 297 60 3 3
POTASSIUM CHLORIDE 273 222 51 4 9
HYDROCODONE-ACETAMINOPHEN 246 159 51 S3 5 1
FENOFIBRATE* 245 176 37 6 83
METFORMIN HCL ER 243 214 48 7 66
OMEPRAZOLE 240 219 48 8 5
ENALAPRIL MALEATE 198 152 41 9 75
ZOLPIDEM TARTRATE 188 128 37 10 24
PRAVASTATIN SODIUM 163 130 37 11 11
CITALOPRAM HBR 151 136 28 12 16
LISINOPRIL 144 126 36 13 2
LORAZEPAM 144 125 26 B 13 31
HYDROCHLOROTHIAZIDE 141 104 30 15 14
TRAMADOL HCL 135 120 36 16 17
AZITHROMYCIN 132 103 92 17 41
METOPROLOL SUCCINATE 128 128 22 18 23
MELOXICAM 127 105 30 19 15
SERTRALINE HCL 126 98 27 20 26
CLOPIDOGREL 122 102 25 21 18
VERAPAMIL ER 117 112* 20 22 92
WARFARIN SODIUM 109 89 14 23 19
FUROSEMIDE 109 77 23 23 7
ATORVASTATIN CALCIUM 109 104* 19 23 13
METOPROLOL TARTRATE 108 80 23 26 12
GABAPENTIN 106 87 22 27 10
GLIMEPIRIDE 96 91* 18 28 37
AMLODIPINE BESYLATE-BENAZEPRIL 95 69 12 29 76
ALLOPURINOL 86 81* 12 30 34
METFORMIN HCL 74 69* 13 31 8
ALPRAZOLAM 74 59 12 B 31 20
TEMAZEPAM 73 68* 21 B 33 93
LOSARTAN POTASSIUM 73 59 16 33 28
PANTOPRAZOLE SODIUM 70 65* 18 35 42
NIASPAN 60 55* 13 36 192
BENICAR HCT 58 <11 <11 37 231
FAMOTIDINE* 56 40 17 38 67
PAROXETINE HCL 55 <11 <11 39 68
ESTRADIOL 54 <11 <11 R 40 84
FLUOXETINE HCL 54 <11 <11 40 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 <11 <11 42 22
TRIAMTERENE-HCTZ 51 <11 <11 43 39
LOSARTAN-HYDROCHLOROTHIAZIDE 50 <11 <11 44 53
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.